Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
11,674
archived clinical trials in
Skin Cancer

Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated:  8/11/2016
Natalie Warren Bryant Cancer Center at St. Francis Hospital
mi
from
Tulsa, OK
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated: 8/11/2016
Natalie Warren Bryant Cancer Center at St. Francis Hospital
mi
from
Tulsa, OK
Click here to add this to my saved trials
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated:  8/11/2016
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated: 8/11/2016
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated:  8/11/2016
Fredericksburg Oncology, Incorporated
mi
from
Fredericksburg, VA
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated: 8/11/2016
Fredericksburg Oncology, Incorporated
mi
from
Fredericksburg, VA
Click here to add this to my saved trials
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated:  8/11/2016
Marshfield Clinic Cancer Care at Regional Cancer Center
mi
from
Eau Claire, WI
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated: 8/11/2016
Marshfield Clinic Cancer Care at Regional Cancer Center
mi
from
Eau Claire, WI
Click here to add this to my saved trials
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated:  8/11/2016
Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated: 8/11/2016
Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
mi
from
Green Bay, WI
Click here to add this to my saved trials
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated:  8/11/2016
Green Bay Oncology, Limited at St. Mary's Hospital
mi
from
Green Bay, WI
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated: 8/11/2016
Green Bay Oncology, Limited at St. Mary's Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated:  8/11/2016
St. Mary's Hospital Medical Center - Green Bay
mi
from
Green Bay, WI
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated: 8/11/2016
St. Mary's Hospital Medical Center - Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated:  8/11/2016
Marshfield Clinic - Lakeland Center
mi
from
Minocqua, WI
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated: 8/11/2016
Marshfield Clinic - Lakeland Center
mi
from
Minocqua, WI
Click here to add this to my saved trials
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated:  8/11/2016
Green Bay Oncology, Limited - Oconto Falls
mi
from
Oconto Falls, WI
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated: 8/11/2016
Green Bay Oncology, Limited - Oconto Falls
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated:  8/11/2016
Marshfield Clinic - Indianhead Center
mi
from
Rice Lake, WI
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated: 8/11/2016
Marshfield Clinic - Indianhead Center
mi
from
Rice Lake, WI
Click here to add this to my saved trials
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated:  8/11/2016
Marshfield Clinic at Saint Michael's Hospital
mi
from
Stevens Point, WI
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated: 8/11/2016
Marshfield Clinic at Saint Michael's Hospital
mi
from
Stevens Point, WI
Click here to add this to my saved trials
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated:  8/11/2016
Green Bay Oncology, Limited - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
A Randomized Phase II Trial of Carboplatin, Paclitaxel, Bevacizumab, With or Without Everolimus for Therapy of Metastatic Malignant Melanoma
Status: Enrolling
Updated: 8/11/2016
Green Bay Oncology, Limited - Sturgeon Bay
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients
A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients, With Evaluation of the Injection Site Microenvironment
Status: Enrolling
Updated:  8/11/2016
University of Virginia
mi
from
Charlottesville, VA
A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients
A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients, With Evaluation of the Injection Site Microenvironment
Status: Enrolling
Updated: 8/11/2016
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Evaluation of a Multi-phosphopeptide Vaccine Plus PolyICLC in Participants With High Risk and Advanced Malignancies
Evaluation of the Safety and Immunogenicity of a Multi-phosphopeptide Vaccine Plus PolyICLC in Participants With High Risk and Advanced Malignancies (Mel59)
Status: Enrolling
Updated:  8/11/2016
University of Virginia
mi
from
Charlottesville, VA
Evaluation of a Multi-phosphopeptide Vaccine Plus PolyICLC in Participants With High Risk and Advanced Malignancies
Evaluation of the Safety and Immunogenicity of a Multi-phosphopeptide Vaccine Plus PolyICLC in Participants With High Risk and Advanced Malignancies (Mel59)
Status: Enrolling
Updated: 8/11/2016
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Ipilimumab + Temozolomide in Metastatic Melanoma
Phase II Study of Ipilimumab Plus Temozolomide in Patients With Metastatic Melanoma
Status: Enrolling
Updated:  8/16/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Ipilimumab + Temozolomide in Metastatic Melanoma
Phase II Study of Ipilimumab Plus Temozolomide in Patients With Metastatic Melanoma
Status: Enrolling
Updated: 8/16/2016
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Ipilimumab Administered to Stage IIIC Stage IV Melanoma After Reg. T Cell Depletion With Denileukin Diftitox
A Phase II Open-Label Study of Ipilimumab Administered to Stage IIIC and Stage IV Melanoma Patients After Regulatory T Cell Depletion With Denileukin Diftitox
Status: Enrolling
Updated:  11/21/2016
James Graham Brown Cancer Center
mi
from
Louisville, KY
Ipilimumab Administered to Stage IIIC Stage IV Melanoma After Reg. T Cell Depletion With Denileukin Diftitox
A Phase II Open-Label Study of Ipilimumab Administered to Stage IIIC and Stage IV Melanoma Patients After Regulatory T Cell Depletion With Denileukin Diftitox
Status: Enrolling
Updated: 11/21/2016
James Graham Brown Cancer Center
mi
from
Louisville, KY
Click here to add this to my saved trials
A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for Treatment of Stage IV Melanoma
Phase I/II Trial of A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for the Treatment of Stage IV Melanoma
Status: Enrolling
Updated:  11/22/2016
James Graham Brown Cancer Center
mi
from
Louisville, KY
A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for Treatment of Stage IV Melanoma
Phase I/II Trial of A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for the Treatment of Stage IV Melanoma
Status: Enrolling
Updated: 11/22/2016
James Graham Brown Cancer Center
mi
from
Louisville, KY
Click here to add this to my saved trials
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/30/2016
International Dermatology Research, Inc.
mi
from
Miami, FL
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/30/2016
International Dermatology Research, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/30/2016
Minnesota Clinical Study Center
mi
from
Fridley, MN
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/30/2016
Minnesota Clinical Study Center
mi
from
Fridley, MN
Click here to add this to my saved trials
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/30/2016
Academic Dermatology Association
mi
from
Albuquerque, NM
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/30/2016
Academic Dermatology Association
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/30/2016
Dermatology Consulting Services
mi
from
High Point, NC
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/30/2016
Dermatology Consulting Services
mi
from
High Point, NC
Click here to add this to my saved trials
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated:  11/30/2016
J&S Studies
mi
from
College Station, TX
Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
A Multi-Center, Double-Blind, Randomized, Vehicle-Controlled, Parallel-Group Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis
Status: Enrolling
Updated: 11/30/2016
J&S Studies
mi
from
College Station, TX
Click here to add this to my saved trials
Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy
Phase I Safety Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy
Status: Enrolling
Updated:  11/30/2016
M.D. Anderson Cancer Center
mi
from
Houston, TX
Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy
Phase I Safety Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy
Status: Enrolling
Updated: 11/30/2016
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma
A Phase I Single Center Study of Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma
Status: Enrolling
Updated:  12/1/2016
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma
A Phase I Single Center Study of Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma
Status: Enrolling
Updated: 12/1/2016
Massachusetts Eye & Ear Infirmary
mi
from
Boston, MA
Click here to add this to my saved trials
Oral N-acetylcysteine for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo
A Phase II Placebo-controlled Intervention Trial of Oral N-acetylcysteine (NAC) for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo
Status: Enrolling
Updated:  12/1/2016
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Oral N-acetylcysteine for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo
A Phase II Placebo-controlled Intervention Trial of Oral N-acetylcysteine (NAC) for Protection of Human Nevi Against UV-induced Oxidative Stress/Damage in Vivo
Status: Enrolling
Updated: 12/1/2016
Huntsman Cancer Institute
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Trial of pIL-12 Electroporation Malignant Melanoma
A Multicenter Phase II Trial of Intratumoral pIL-12 Electroporation in Advanced Stage Cutaneous and in Transit Malignant Melanoma
Status: Enrolling
Updated:  12/12/2016
UCSF Helen Diller Comprehensive Cancer Center
mi
from
San Francisco, CA
Trial of pIL-12 Electroporation Malignant Melanoma
A Multicenter Phase II Trial of Intratumoral pIL-12 Electroporation in Advanced Stage Cutaneous and in Transit Malignant Melanoma
Status: Enrolling
Updated: 12/12/2016
UCSF Helen Diller Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Trial of pIL-12 Electroporation Malignant Melanoma
A Multicenter Phase II Trial of Intratumoral pIL-12 Electroporation in Advanced Stage Cutaneous and in Transit Malignant Melanoma
Status: Enrolling
Updated:  12/12/2016
John Wayne Cancer Institute
mi
from
Santa Monica, CA
Trial of pIL-12 Electroporation Malignant Melanoma
A Multicenter Phase II Trial of Intratumoral pIL-12 Electroporation in Advanced Stage Cutaneous and in Transit Malignant Melanoma
Status: Enrolling
Updated: 12/12/2016
John Wayne Cancer Institute
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Trial of pIL-12 Electroporation Malignant Melanoma
A Multicenter Phase II Trial of Intratumoral pIL-12 Electroporation in Advanced Stage Cutaneous and in Transit Malignant Melanoma
Status: Enrolling
Updated:  12/12/2016
University of Colorado at Denver
mi
from
Denver, CO
Trial of pIL-12 Electroporation Malignant Melanoma
A Multicenter Phase II Trial of Intratumoral pIL-12 Electroporation in Advanced Stage Cutaneous and in Transit Malignant Melanoma
Status: Enrolling
Updated: 12/12/2016
University of Colorado at Denver
mi
from
Denver, CO
Click here to add this to my saved trials
Trial of pIL-12 Electroporation Malignant Melanoma
A Multicenter Phase II Trial of Intratumoral pIL-12 Electroporation in Advanced Stage Cutaneous and in Transit Malignant Melanoma
Status: Enrolling
Updated:  12/12/2016
Lakeland Regional Cancer Center
mi
from
Lakeland, FL
Trial of pIL-12 Electroporation Malignant Melanoma
A Multicenter Phase II Trial of Intratumoral pIL-12 Electroporation in Advanced Stage Cutaneous and in Transit Malignant Melanoma
Status: Enrolling
Updated: 12/12/2016
Lakeland Regional Cancer Center
mi
from
Lakeland, FL
Click here to add this to my saved trials
Trial of pIL-12 Electroporation Malignant Melanoma
A Multicenter Phase II Trial of Intratumoral pIL-12 Electroporation in Advanced Stage Cutaneous and in Transit Malignant Melanoma
Status: Enrolling
Updated:  12/12/2016
St. Luke's University Health Network
mi
from
Bethlehem, PA
Trial of pIL-12 Electroporation Malignant Melanoma
A Multicenter Phase II Trial of Intratumoral pIL-12 Electroporation in Advanced Stage Cutaneous and in Transit Malignant Melanoma
Status: Enrolling
Updated: 12/12/2016
St. Luke's University Health Network
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Trial of pIL-12 Electroporation Malignant Melanoma
A Multicenter Phase II Trial of Intratumoral pIL-12 Electroporation in Advanced Stage Cutaneous and in Transit Malignant Melanoma
Status: Enrolling
Updated:  12/12/2016
Seattle Cancer Care Alliance /University of Washington Cancer Consortium
mi
from
Seattle, WA
Trial of pIL-12 Electroporation Malignant Melanoma
A Multicenter Phase II Trial of Intratumoral pIL-12 Electroporation in Advanced Stage Cutaneous and in Transit Malignant Melanoma
Status: Enrolling
Updated: 12/12/2016
Seattle Cancer Care Alliance /University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Mayo Clinic Scottsdale
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
St. Francis Hospital and Health Centers - Beech Grove Campus
mi
from
Beech Grove, IN
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
St. Francis Hospital and Health Centers - Beech Grove Campus
mi
from
Beech Grove, IN
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
McFarland Clinic, PC
mi
from
Ames, IA
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
McFarland Clinic, PC
mi
from
Ames, IA
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
Cedar Rapids Oncology Associates
mi
from
Cedar Rapids, IA
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Cedar Rapids Oncology Associates
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
Mercy Capitol Hospital
mi
from
Des Moines, IA
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Mercy Capitol Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
John Stoddard Cancer Center at Iowa Methodist Medical Center
mi
from
Des Moines, IA
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
John Stoddard Cancer Center at Iowa Methodist Medical Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
Medical Oncology and Hematology Associates at John Stoddard Cancer Center
mi
from
Des Moines, IA
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Medical Oncology and Hematology Associates at John Stoddard Cancer Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
Medical Oncology and Hematology Associates at Mercy Cancer Center
mi
from
Des Moines, IA
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Medical Oncology and Hematology Associates at Mercy Cancer Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
Mercy Cancer Center at Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Mercy Cancer Center at Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
John Stoddard Cancer Center at Iowa Lutheran Hospital
mi
from
Des Moines, IA
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
John Stoddard Cancer Center at Iowa Lutheran Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Siouxland Hematology-Oncology Associates, LLP
mi
from
Sioux City, IA
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Mercy Medical Center - Sioux City
mi
from
Sioux City, IA
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
St. Luke's Regional Medical Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
Medical Oncology and Hematology Associates - West Des Moines
mi
from
West Des Moines, IA
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Medical Oncology and Hematology Associates - West Des Moines
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
Fairview Ridges Hospital
mi
from
Burnsville, MN
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Fairview Ridges Hospital
mi
from
Burnsville, MN
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
Mercy and Unity Cancer Center at Mercy Hospital
mi
from
Coon Rapids, MN
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Mercy and Unity Cancer Center at Mercy Hospital
mi
from
Coon Rapids, MN
Click here to add this to my saved trials
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated:  12/14/2016
Fairview Southdale Hospital
mi
from
Edina, MN
Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System
A Systemic Temozolomide Treatment Of Melanoma Present In The Central Nervous System
Status: Enrolling
Updated: 12/14/2016
Fairview Southdale Hospital
mi
from
Edina, MN
Click here to add this to my saved trials